Pharmigene, Inc. (TPEX:7595)

Pharmigene Revenue

Pharmigene had revenue of 68.66M TWD in the half year ending June 30, 2026, with 43.18% growth. This brings the company's revenue in the last twelve months to 187.88M, up 25.88% year-over-year. In the year 2025, Pharmigene had annual revenue of 199.89M with 71.53% growth.

• Revenue (ttm): 187.88M
• Revenue Growth: +25.88%
• P/S Ratio: 1.97
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 369.91M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	199.89M	83.36M	71.53%
Dec 31, 2024	116.53M	-16.17M	-12.19%
Dec 31, 2023	132.71M	-1.09M	-0.82%
Dec 31, 2022	133.80M	4.45M	3.44%
Dec 31, 2021	129.35M	28.00M	27.63%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 5, 2026

Data Sources Report a data error